Soft Drinks and Symptoms of Depression and Anxiety in Overweight Subjects: A Longitudinal Analysis of an European Cohort.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
05 Sep 2023
Historique:
received: 11 07 2023
revised: 11 08 2023
accepted: 31 08 2023
medline: 29 9 2023
pubmed: 28 9 2023
entrez: 28 9 2023
Statut: epublish

Résumé

Studies about the association of carbonated/soft drinks, coffee, and tea with depression and anxiety are scarce and inconclusive and little is known about this association in European adults. Our aim was to examine the association between the consumption of these beverages and depressive and anxiety symptom severity. A total of 941 European overweight adults (mean age, 46.8 years) with subsyndromal depression that participated in the MooDFOOD depression prevention randomized controlled trial (Clinical Trials.gov identifier: NCT2529423; date of the study: from 2014 to 2018) were analyzed. Depressive and anxiety symptom severity and beverage consumption were assessed using multilevel mixed-effects ordinal logistic regression models for each beverage consumption (carbonated/soft drink with sugar, carbonated/soft drink with non-nutritive sweeteners, coffee, and tea) with the three repeated measures of follow-up (baseline and 6 and 12 months). A case report form for participants' sociodemographic and clinical characteristics, the Food Frequency Questionnaire, the Patient Health Questionnaire-9, the Generalized Anxiety Disorder 7-Item Scale, the MINI International Neuropsychiatric Interview 5.0, the Short Questionnaire to Assess Health-Enhancing Psychical Activity, and the Alcohol Use Disorders Identification Test were the research tools used. Daily consumption of carbonated/soft drinks with sugar was associated with a higher level of anxiety. Trends towards significance were found for associations between both daily consumption of carbonated/soft drinks with sugar and non-nutritive sweeteners and a higher level of depression. No relationship was found between coffee and tea consumption and the level of depression and anxiety. The high and regular consumption of carbonated/soft drink with sugar (amount of consumption: ≥1 unit (200 mL)/day) tended to be associated with higher level of anxiety in a multicountry sample of overweight subjects with subsyndromal depressive symptoms. It is important to point out that further research in this area is essential to provide valuable information about the intake patterns of non-alcoholic beverages and their relationship with affective disorders in the European adult population.

Sections du résumé

BACKGROUND BACKGROUND
Studies about the association of carbonated/soft drinks, coffee, and tea with depression and anxiety are scarce and inconclusive and little is known about this association in European adults. Our aim was to examine the association between the consumption of these beverages and depressive and anxiety symptom severity.
METHODS METHODS
A total of 941 European overweight adults (mean age, 46.8 years) with subsyndromal depression that participated in the MooDFOOD depression prevention randomized controlled trial (Clinical Trials.gov identifier: NCT2529423; date of the study: from 2014 to 2018) were analyzed. Depressive and anxiety symptom severity and beverage consumption were assessed using multilevel mixed-effects ordinal logistic regression models for each beverage consumption (carbonated/soft drink with sugar, carbonated/soft drink with non-nutritive sweeteners, coffee, and tea) with the three repeated measures of follow-up (baseline and 6 and 12 months). A case report form for participants' sociodemographic and clinical characteristics, the Food Frequency Questionnaire, the Patient Health Questionnaire-9, the Generalized Anxiety Disorder 7-Item Scale, the MINI International Neuropsychiatric Interview 5.0, the Short Questionnaire to Assess Health-Enhancing Psychical Activity, and the Alcohol Use Disorders Identification Test were the research tools used.
RESULTS RESULTS
Daily consumption of carbonated/soft drinks with sugar was associated with a higher level of anxiety. Trends towards significance were found for associations between both daily consumption of carbonated/soft drinks with sugar and non-nutritive sweeteners and a higher level of depression. No relationship was found between coffee and tea consumption and the level of depression and anxiety.
CONCLUSIONS CONCLUSIONS
The high and regular consumption of carbonated/soft drink with sugar (amount of consumption: ≥1 unit (200 mL)/day) tended to be associated with higher level of anxiety in a multicountry sample of overweight subjects with subsyndromal depressive symptoms. It is important to point out that further research in this area is essential to provide valuable information about the intake patterns of non-alcoholic beverages and their relationship with affective disorders in the European adult population.

Identifiants

pubmed: 37764652
pii: nu15183865
doi: 10.3390/nu15183865
pmc: PMC10536294
pii:
doi:

Substances chimiques

Coffee 0
Non-Nutritive Sweeteners 0
Sugars 0
Tea 0

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : European Union FP7 MooDFOOD Project "Multi-country collaborative project on the role of diet, food-related behaviour, and obesity in the prevention of depression"
ID : grant agreement no. 613598

Références

Environ Health Prev Med. 2019 Feb 26;24(1):13
pubmed: 30808291
Nutrients. 2021 Dec 30;14(1):
pubmed: 35011043
Public Health Nutr. 2019 Oct;22(14):2553-2560
pubmed: 31097051
Nutr J. 2020 Jan 9;19(1):2
pubmed: 31918726
Braz J Psychiatry. 2021 Nov-Dec;43(6):574-583
pubmed: 33331496
Saudi Pharm J. 2020 Apr;28(4):445-451
pubmed: 32273803
Nutrients. 2021 Nov 23;13(12):
pubmed: 34959744
Eur J Clin Nutr. 2011 Jun;65(6):750-6
pubmed: 21427744
Gen Hosp Psychiatry. 2022 Jan-Feb;74:22-31
pubmed: 34871964
JAMA. 2019 Mar 5;321(9):858-868
pubmed: 30835307
J Alzheimers Dis. 2010;20 Suppl 1:S239-48
pubmed: 20164571
Psychiatry Res. 2019 Jan;271:732-739
pubmed: 30791349
Public Health Nutr. 2010 Jul;13(7):1073-9
pubmed: 20074392
Int J Environ Res Public Health. 2021 Aug 10;18(16):
pubmed: 34444180
J Affect Disord. 2015 Feb 1;172:422-7
pubmed: 25451447
Front Nutr. 2023 Feb 09;10:1051444
pubmed: 36845051
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Lancet Diabetes Endocrinol. 2016 Feb;4(2):174-86
pubmed: 26654575
Food Chem Toxicol. 1996 Jan;34(1):119-29
pubmed: 8603790
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Phytomedicine. 2017 Oct 15;34:26-37
pubmed: 28899506
Plant Foods Hum Nutr. 2020 Mar;75(1):12-23
pubmed: 31758301
Public Health Nutr. 2022 Jan 31;:1-28
pubmed: 35094730
Front Psychiatry. 2020 May 26;11:458
pubmed: 32528328
Nutrients. 2020 Oct 20;12(10):
pubmed: 33092067
J Psychiatr Res. 2019 Mar;110:31-37
pubmed: 30580081
J Epidemiol. 2020 Aug 5;30(8):338-344
pubmed: 31231097
Nutrients. 2021 Aug 07;13(8):
pubmed: 34444884
Nutrition. 2021 Jan;81:110860
pubmed: 32791444
J Clin Epidemiol. 2003 Dec;56(12):1163-9
pubmed: 14680666
J Public Health Policy. 2012 Feb;33(1):75-88
pubmed: 21866177
J Nutr Health Aging. 2021;25(3):295-301
pubmed: 33575719
BMC Psychiatry. 2016 Jun 08;16:192
pubmed: 27277946
Nutr Res. 2022 Jul;103:59-67
pubmed: 35477125
Lancet Psychiatry. 2016 Feb;3(2):171-8
pubmed: 26851330
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941

Auteurs

Adoración Castro (A)

Research Institute of Health Sciences (IUNICS), University of the Balearic Islands (UIB), 07122 Palma de Mallorca, Spain.
Health Research Institute of the Balearic Islands (IdISBa), Hospital Universitario Son Espases, Edificio S, 07120 Palma de Mallorca, Spain.
Department of Psychology, University of the Balearic Islands (UIB), 07122 Palma de Mallorca, Spain.

Margalida Gili (M)

Research Institute of Health Sciences (IUNICS), University of the Balearic Islands (UIB), 07122 Palma de Mallorca, Spain.
Health Research Institute of the Balearic Islands (IdISBa), Hospital Universitario Son Espases, Edificio S, 07120 Palma de Mallorca, Spain.
Department of Psychology, University of the Balearic Islands (UIB), 07122 Palma de Mallorca, Spain.

Marjolein Visser (M)

Department of Health Sciences, Faculty of Science, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.

Brenda W J H Penninx (BWJH)

Department of Psychiatry, Amsterdam Public Health Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

Ingeborg A Brouwer (IA)

Department of Health Sciences, Faculty of Science, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.

Juan José Montaño (JJ)

Health Research Institute of the Balearic Islands (IdISBa), Hospital Universitario Son Espases, Edificio S, 07120 Palma de Mallorca, Spain.
Department of Psychology, University of the Balearic Islands (UIB), 07122 Palma de Mallorca, Spain.

María Ángeles Pérez-Ara (MÁ)

Research Institute of Health Sciences (IUNICS), University of the Balearic Islands (UIB), 07122 Palma de Mallorca, Spain.

Mauro García-Toro (M)

Research Institute of Health Sciences (IUNICS), University of the Balearic Islands (UIB), 07122 Palma de Mallorca, Spain.
Health Research Institute of the Balearic Islands (IdISBa), Hospital Universitario Son Espases, Edificio S, 07120 Palma de Mallorca, Spain.
Department of Medicine, University of the Balearic Islands (UIB), 07122 Palma de Mallorca, Spain.

Ed Watkins (E)

Department of Psychology, University of Exeter, Exeter EX4 4PY, UK.

Matt Owens (M)

Department of Psychology, University of Exeter, Exeter EX4 4PY, UK.

Ulrich Hegerl (U)

Department of Psychiatry, Psychosomatics and Psychotherapy, Goethe Universität Frankfurt am Main, 60528 Frankfurt am Main, Germany.

Elisabeth Kohls (E)

Department of Psychiatry and Psychotherapy, Medical Faculty, University Leipzig, 04109 Leipzig, Germany.

Mariska Bot (M)

Department of Psychiatry, Amsterdam Public Health Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

Miquel Roca (M)

Research Institute of Health Sciences (IUNICS), University of the Balearic Islands (UIB), 07122 Palma de Mallorca, Spain.
Health Research Institute of the Balearic Islands (IdISBa), Hospital Universitario Son Espases, Edificio S, 07120 Palma de Mallorca, Spain.
Department of Medicine, University of the Balearic Islands (UIB), 07122 Palma de Mallorca, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH